07.01.14
DuPont Nutrition & Health has obtained a probiotic health claim in Europe in collaboration with a major Swiss grocer. The approval from Switzerland’s Federal Food Safety and Veterinary Office (FSVO) allows Dupont to market Danisco HOWARU Bifidobacterium lactis HN019 probiotic as supporting digestion by reducing transit time.
“DuPont Nutrition & Health applauds the Swiss authorities for approving a structure function claim on scientifically backed Bifidobacterium lactis HN019,” said Fabienne Saadane-Oaks, vice president Health and Protection, DuPont Nutrition & Health. “This approval validates the strong evidence we have on the link between digestive health and probiotics—support for an important milestone that we hope prompts other countries to follow suit.” DuPont will be filing dossiers in other European countries as well.
DuPont also recently signed a global collaboration and licensing agreement with AB-Biotics for AB-Life, a probiotic that is clinically documented to maintain healthy levels of cholesterol in at-risk individuals. Under the agreement, DuPont will have exclusive rights for the production, marketing and sales of AB-Life; and AB-Biotics will continue to conduct clinical research to further substantiate the proven health benefits of AB-Life.
“DuPont Nutrition & Health applauds the Swiss authorities for approving a structure function claim on scientifically backed Bifidobacterium lactis HN019,” said Fabienne Saadane-Oaks, vice president Health and Protection, DuPont Nutrition & Health. “This approval validates the strong evidence we have on the link between digestive health and probiotics—support for an important milestone that we hope prompts other countries to follow suit.” DuPont will be filing dossiers in other European countries as well.
DuPont also recently signed a global collaboration and licensing agreement with AB-Biotics for AB-Life, a probiotic that is clinically documented to maintain healthy levels of cholesterol in at-risk individuals. Under the agreement, DuPont will have exclusive rights for the production, marketing and sales of AB-Life; and AB-Biotics will continue to conduct clinical research to further substantiate the proven health benefits of AB-Life.
